Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Anthony Scialli

Gynecology Washington, DC Medical Doctor

NPI 1538360714 CMS profile 663257

2150 Pennsylvania Ave Nw, Suite 10-409A, Washington, DC 20037

Open in the dashboard

General payments

$164,960

111 records reported · program years 2019–2025

Research payments

$20,683

Paid to them · 20 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$51,849 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Anthony Scialli of Washington, DC is reported in the CMS Open Payments database as having received $164,960 across 111 general payments and $20,683 in research payments paid to them. Separately, studies naming them as principal investigator received $51,849 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $10,379 13
2025 Research $425 2
2024 General $7,487 10
2024 Research $2,388 5
2023 General $12,269 19
2022 General $45,906 25
2022 Research $1,838 4
2021 General $39,679 11
2021 Research $1,628 2
2020 General $25,772 16
2020 Research $7,288 4
2019 General $23,470 17
2019 Research $7,117 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anthony Scialli
  • Gynecology median
  • Middle half of Gynecology
  • National median

In program year 2025, general payments to Anthony Scialli were reported at $10,379. Among 1,279 Gynecology profiles paid that year, the median was $162 and the middle half received between $56 and $501.

Show as a table
Year Anthony Scialli Gynecology median Middle half National median
2019 $23,470 $199 $66–$472 $163
2020 $25,772 $114 $42–$287 $114
2021 $39,679 $141 $42–$430 $132
2022 $45,906 $173 $52–$532 $149
2023 $12,269 $170 $57–$501 $160
2024 $7,487 $157 $50–$424 $164
2025 $10,379 $162 $56–$501 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Merck Sharp & Dohme Corporation $27,761 5 payments
  2. Seqirus USA Inc $19,276 19 payments
  3. Xellia Pharmaceuticals $15,951 4 payments
  4. Sanofi-Aventis U.S. LLC $15,515 8 payments
  5. Sanofi US Services Inc. $15,003 2 payments
  6. Vertex Pharmaceuticals Incorporated $13,611 19 payments
  7. Mitsubishi Tanabe Pharma Development America, Inc. $12,750 4 payments
  8. AbbVie, Inc. $12,138 14 payments
  9. Novartis Pharma AG $8,609 7 payments
  10. Jazz Pharmaceuticals Inc. $7,383 10 payments
  11. Other $16,966 19 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $157,828 101 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,150 1 payment
  3. Travel and Lodging $711 4 payments
  4. Food and Beverage $272 5 payments
Products named General payments · program years 2019–2025
  1. Vancomycin $15,951 4 payments
  2. NO PRODUCT DISCUSSED $9,563 1 payment
  3. NURTEC ODT $8,423 16 payments
  4. MAKENA $6,563 1 payment
  5. FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL) $5,857 5 payments
  6. GILENYA $4,641 3 payments
  7. FTY720D_GILENYA_NEUROSCIENCE $3,968 4 payments
  8. JZP-150 $2,700 3 payments
  9. AFLURIA QUADRIVALENT $2,613 2 payments
  10. SKYRIZI $2,500 4 payments
  11. Other $12,683 13 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Teva Pharmaceuticals USA, Inc. $8,355 5 payments
  2. Novo Nordisk AS $6,490 3 payments
  3. Amryt Pharma Holdings Ltd $1,838 4 payments
  4. Amgen Inc. $1,188 1 payment
  5. Sumitomo Pharma America, Inc. $1,125 3 payments
  6. Celgene Corporation $1,025 1 payment
  7. Chiesi USA, Inc. $413 2 payments
  8. Harmony Biosciences LLC $250 1 payment

Records

131 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gynecology in District of Columbia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record